Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 2/20 | 0.64 |
| ▸ | ROCK2 | O75116 | 12/20 | 0.45 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.44 |
| ▸ | AGPAT2 | O15120 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.39 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8320445 | 0.84 | ROCK1 (0.73) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL13288551 | 0.84 | ROCK1 (0.75) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL2876588 | 0.82 | ROCK1 (0.73) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL8320486 | 0.81 | ROCK1 (0.71) | ROCK1ROCK2MAPKAPK2CYP3A4KDR | |
| SCHEMBL13288470 | 0.79 | ROCK1 (0.82) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL2881723 | 0.79 | ROCK1 (0.66) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL8328328 | 0.79 | ROCK1 (0.85) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL2883920 | 0.79 | ROCK1 (0.85) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL8333105 | 0.79 | ROCK1 (0.76) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 | |
| SCHEMBL13288477 | 0.79 | ROCK1 (0.76) | ROCK1ROCK2MAPKAPK2AGPAT2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737153-B2 | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-06-15 | — | — | US | disclosed |
| US-7737153-B2 | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-06-15 | — | — | US | disclosed |